Mast cell infiltration in acute coronary syndromes: Implications for plaque rupture

Journal of the American College of Cardiology

Volumn 32, Issue 3, 1998, Pages 606-612

  Kaartinen, Maija ^a,b   Van Der Wal, Allard C ^c   Van Der Loos, Chris M ^c   Piek, Jan J ^c   Koch, Karel T ^c   Becker, Anton E ^c   Kovanen, Petri T ^a  

^a WIHURI RESEARCH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN E; TUMOR NECROSIS FACTOR ALPHA;

ANGINA PECTORIS; ARTICLE; ATHERECTOMY; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MAST CELL DEGRANULATION; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; UNSTABLE ANGINA PECTORIS;

EID: 0031668342     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00283-6     Document Type: Article

References (31)

1. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;242-250.
2. Falk E. Why do plaques rupture? Circulation. 86:(Suppl III):1992;30-42.
3. Moreno P.R., Falk E., Palacios J.F., Newell J.B., Fuster V., Fallon J.T. Macrophage infiltration in acute coronary syndromes Implications for plaque rupture . Circulation. 90:1994;775-778.
4. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:1994;36-44.
5. van der Wal A.C., Becker A.E., Koch K.T., et al. Clinically stable angina pectoris is not necessarily associated with histologically stable atherosclerotic plaques. Heart. 76:1996;312-316.
6. Kovanen P.T., Kaartinen M., Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 92:1995;1084-1088.
7. Austen K.F. The heterogeneity of mast cell populations and products. Hosp Pract. 19:1984;135-146.
8. Irani A.A., Schechter N.M., Craig S.S., DeBlois G., Schwartz L.B. Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA. 83:1986;4464-4468.
9. Hibbs M.S., Hoidal J.R., Kang A.H. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J Clin Invest. 80:1987;1644-1650.
10. Wilhelm S.M., Collier I.E., Marmer B.L., Eisen A.Z., Grant G.A., Goldberg G.I. SV-40-transformed human lung fibroblasts secrete a 92kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem. 264:1989;17213-17221.
11. Kaartinen M., Penttilä A., Kovanen P.T. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 90:1994;1669-1678.
12. Kaartinen M., Penttilä A., Kovanen P.T. Mast cells in rupture-prone areas of human coronary atheromas produce and store TNF-α Circulation. 94:1996;2787-2792.
13. Saren P., Welgus H.G., Kovanen P.T. TNF-α and IL-1β selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol. 157:1996;4159-4165.
14. Brown D.L., Hibbs M.S., Kearney M., Loushin C., Isner J.M. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions association of active enzyme synthesis with unstable angina . Circulation. 91:1995;2125-2131.
15. TC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem. 37:1989;1509-1515.
16. McCullagh P., Nelder J.A. Generalized Linear Models. 2nd ed. 1989;98 Chapman & Hall, London.
17. Ishizaka T., Ishizaka K. Activation of mast cells for mediator release through IgE receptors. Prog Allergy. 34:1984;188-235.
18. Criqui M.H., Lee E.R., Hamburger R.N., Klauber M.R., Coughlin S.S. IgE and cardiovascular disease results from a population-based study . Am J Med. 82:1987;964-968.
19. Langer R.D., Criqui M.H., Feigelson H.S., McCann T.J., Hamburger R.N. IgE predicts future nonfatal myocardial infarction in men. J Clin Epidemiol. 49:1996;203-209.
20. Sedgwick J.D., Holt P.G., Turner K.J. Production of a histamine-releasing lymphokine by antigen- or mitogen-stimulated human peripheral T cells. Clin Exp Immunol. 45:1981;409-418.
21. Liu M.C., Proud D., Lichtenstein L.M., et al. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. J Immunol. 136:1986;2588-2595.
22. Henney A.M., Wakeley P.R., Davies M.J., et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA. 88:1991;8154-8158.
23. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 94:1994;2493-2503.
24. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 91:1995;2844-2850.
25. Gruber B.L., Marchese M.J., Suzuki K., et al. Synovial procollagenase activation by human mast cell tryptase Dependence upon matrix metalloproteinase 3 activation . J Clin Invest. 84:1989;1657-1662.
26. 84 bond by mast cell chymase. J Biol Chem. 269:1994;18134-18140.
27. Tyagi S.C., Meyer L., Schmaltz R.A., Reddy H.K., Voelker D.J. Proteinases and restenosis in the human coronary artery extracellular matrix production exceeds the expression of proteolytic activity . Atherosclerosis. 116:1995;43-57.
28. Galli S.J. New concepts about the mast cell. N Engl J Med. 328:1993;257-265.
29. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circulation. 77:1995;863-868.
30. Lohi J., Harvima I., Keski-Oja J. Pericellular substrates of human mast cell tryptase 72000 dalton gelatinase and fibronectin . J Cell Biochem. 50:1992;337-349.
31. Vartio T., Seppä H., Vaheri A. Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J Biol Chem. 256:1981;471-477.